GITNUX MARKETDATA REPORT 2024

Report: Candida Auris Death Rate Statistics

With sources from: bbc.com, jamanetwork.com, academic.oup.com, ncbi.nlm.nih.gov and many more

Statistic 1

Candida auris is associated with a 30-60% mortality rate.

Statistic 2

There are approximately 3,400 diagnosed cases of Candida auris in the entire U.S.

Statistic 3

The overall death rate from Candida auris can be as high as 50% within 90 days.

Statistic 4

90% of C. auris strains are resistant to at least one antifungal drug.

Statistic 5

Among 204 patient case studies, there was a 29% crude in-hospital mortality rate associated with Candida auris.

Statistic 6

45% of patients with invasive Candida auris infection die within 30 days.

Statistic 7

In New York, 2013-2017, approximately 50% of patients with bloodstream infections died within 90 days.

Statistic 8

The all-age mortality rate was 0.03 per 100,000 population in the United States in 2017.

Statistic 9

41% of C. auris infected patients in Illinois died within 90 days.

Statistic 10

A recent outbreak in a Spanish hospital reported a crude mortality rate of 72%.

Statistic 11

In a South African hospital, 88% of patients with C. auris candidaemia died.

Statistic 12

It is estimated that more than 1 in 3 people with invasive Candida auris infection (for example, an infection that affects the blood, heart, or brain) die, according to clinical cases.

Statistic 13

In a Chicago outbreak of Candida auris, 5/29 (17%) died from the infection.

Statistic 14

Candida auris bloodstream infections were associated with a 28-day all-cause mortality of 60% in UK.

Statistic 15

About 61% of patients with candidemia, due to C . auris, died within a Spanish hospital study.

Statistic 16

A study in India reported a case fatality rate of 90%.

Statistic 17

According to a UK study, mortality rate due to C. auris bloodstream infection was 59%.

Statistic 18

The percentage of patients with C .auris who die at 30 days after the candidemia diagnosis was 32% in a Venezuelan hospital.

Sources Icon Sources

In this post, we will explore the concerning statistics surrounding Candida auris, a deadly fungal infection that has been causing alarm within the healthcare community. With mortality rates ranging from 30% to as high as 90% in some cases, the impact of this infection on patients is significant. From resistance to antifungal drugs to high death rates within various regions and healthcare settings, understanding the statistics related to Candida auris is crucial for ensuring effective prevention and treatment strategies.

Statistic 1

"Candida auris is associated with a 30-60% mortality rate."

Sources Icon

Statistic 2

"There are approximately 3,400 diagnosed cases of Candida auris in the entire U.S."

Sources Icon

Statistic 3

"The overall death rate from Candida auris can be as high as 50% within 90 days."

Sources Icon

Statistic 4

"90% of C. auris strains are resistant to at least one antifungal drug."

Sources Icon

Statistic 5

"Among 204 patient case studies, there was a 29% crude in-hospital mortality rate associated with Candida auris."

Sources Icon

Statistic 6

"45% of patients with invasive Candida auris infection die within 30 days."

Sources Icon

Statistic 7

"In New York, 2013-2017, approximately 50% of patients with bloodstream infections died within 90 days."

Sources Icon

Statistic 8

"The all-age mortality rate was 0.03 per 100,000 population in the United States in 2017."

Sources Icon

Statistic 9

"41% of C. auris infected patients in Illinois died within 90 days."

Sources Icon

Statistic 10

"A recent outbreak in a Spanish hospital reported a crude mortality rate of 72%."

Sources Icon

Statistic 11

"In a South African hospital, 88% of patients with C. auris candidaemia died."

Sources Icon

Statistic 12

"It is estimated that more than 1 in 3 people with invasive Candida auris infection (for example, an infection that affects the blood, heart, or brain) die, according to clinical cases."

Sources Icon

Statistic 13

"In a Chicago outbreak of Candida auris, 5/29 (17%) died from the infection."

Sources Icon

Statistic 14

"Candida auris bloodstream infections were associated with a 28-day all-cause mortality of 60% in UK."

Sources Icon

Statistic 15

"About 61% of patients with candidemia, due to C . auris, died within a Spanish hospital study."

Sources Icon

Statistic 16

"A study in India reported a case fatality rate of 90%."

Sources Icon

Statistic 17

"According to a UK study, mortality rate due to C. auris bloodstream infection was 59%."

Sources Icon

Statistic 18

"The percentage of patients with C .auris who die at 30 days after the candidemia diagnosis was 32% in a Venezuelan hospital."

Sources Icon

Interpretation

The statistics presented reveal a grim reality regarding Candida auris infections, with mortality rates ranging from 30% to as high as 90% in different studies and outbreaks. These numbers underscore the severity of this emerging pathogen and the challenges it poses in terms of treatment and containment. The high rates of antifungal resistance coupled with the significant percentage of patients succumbing to the infection within a relatively short timeframe emphasize the urgent need for improved prevention strategies, more effective treatments, and heightened awareness among healthcare providers to combat the growing threat of Candida auris.

Can You Trust Our Report?

The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.

Learn more about our process here.

Submit Your Own Statistic Data

Would you like to submit your own researched statistics on this topic? You are welcome to use the form below and submit your suggestion to us. We will check the source and approve it if necessary.

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!